Role of positron emission tomography in decisions on treatment strategies for pancreatic cancer

This publication has 27 references indexed in Scilit:

• Positron Emission Tomography Does Not Add to Computed Tomography for the Diagnosis and Staging of Pancreatic Cancer
  Digestive Surgery, 2005
• Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: A preliminary report
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Diagnostic Imaging for Pancreatic Cancer
  Pancreas, 2004
• Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment
  Journal of Clinical Oncology, 2004
• Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment
  Journal of Hepato-Biliary-Pancreatic Surgery, 2004
• Positron emission tomography with 2-deoxy-2-[ 18 F] fluoro-d-glucose for diagnosis of intraductal papillary mucinous tumor of the pancreas with parenchymal invasion
  The Esophagus, 2003
• Detection of recurrent oral squamous cell carcinoma by [¹⁸F]-2-fluorodeoxyglucose-positron emission tomography
  Cancer, 2003
• Laparoscopic Staging and Subsequent Palliation in Patients With Peripancreatic Carcinoma
  Annals of Surgery, 2003
• Carcinoma of the Pancreatic Head and Periampullary Region Tumor Staging with Laparoscopy and Laparoscopic Ultrasonography
  Annals of Surgery, 1995
• PET with fluorine-18 deoxyglucose for pancreatic disease
  The Lancet, 1992